Application of active glucose monitoring in the perioperative period of gastrointestinal endoscopy in children with glycogen storage disease type Ⅰb.
10.7499/j.issn.1008-8830.2412155
- Author:
Jing YANG
1
;
Hao-Tian WU
;
Ni MA
1
;
Jia-Xing WU
1
;
Min YANG
1
Author Information
1. Department of Pediatrics, Guangdong Provincial People's Hospital/Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou 510080, China.
- Publication Type:Journal Article
- Keywords:
Active blood glucose monitoring;
Child;
Gastrointestinal endoscopy;
Glycogen storage disease;
Hypoglycemia;
Perioperative period
- MeSH:
Humans;
Female;
Male;
Child;
Retrospective Studies;
Blood Glucose/analysis*;
Hypoglycemia/etiology*;
Glycogen Storage Disease Type I/blood*;
Endoscopy, Gastrointestinal;
Perioperative Period;
Child, Preschool;
Adolescent
- From:
Chinese Journal of Contemporary Pediatrics
2025;27(8):923-928
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVES:To investigate the role of active glucose monitoring in preventing hypoglycemia during the perioperative period of gastrointestinal endoscopy in children with glycogen storage disease type Ⅰb (GSD-Ⅰb).
METHODS:A retrospective analysis was performed for the clinical data of children with GSD-Ⅰb who were diagnosed and treated in Guangdong Provincial People's Hospital from June 2021 to August 2024. The effect of active glucose monitoring on hypoglycemic episodes during the perioperative period of gastrointestinal endoscopy was analyzed.
RESULTS:A total of 14 children with GSD-Ⅰb were included, among whom there were 7 boys and 7 girls, with a mean age of 10.0 years. Among 34 hospitalizations, there were 15 cases of hypoglycemic episodes (44%), among which 6 symptomatic cases (1 case with blood glucose level of 1.6 mmol/L and 5 cases with blood glucose level of <1.1 mmol/L) occurred without active monitoring, while 9 asymptomatic cases (with blood glucose level of 1.2-3.9 mmol/L) were detected by active monitoring. The predisposing factors for hypoglycemic episodes included preoperative fasting (5 cases, 33%), delayed feeding (7 cases, 47%), vomiting (2 cases, 13%), and parental omission (1 case, 7%). Two children experienced two hypoglycemic episodes during the same period of hospitalization, and no child experienced subjective symptoms prior to hypoglycemic episodes. Treatment methods included nasogastric glucose administration (1 case, 7%), intravenous injection of glucose (14 cases, 93%), and continuous glucose infusion (4 cases, 27%). Blood glucose returned to 3.5-6.9 mmol/L within 10 minutes after intervention and remained normal after dietary resumption.
CONCLUSIONS:Active glucose monitoring during the perioperative period of gastrointestinal endoscopy can help to achieve early detection of hypoglycemic states in children with GSD-Ⅰb, prevent hypoglycemic episodes, and enhance precise diagnosis and treatment.
